Latest Share Chat

REMOVE ADS

Biopharma Cred. Share News (BPCR)

Biopharma Cred. Information

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes

Get Live Data

0.946 0.00 (0.00%)

Bid:

0.00

Ask:

0.00

Spread: 0.002 (0.212%)

Market Cap: $1.06b

Last checked at -

Intraday Biopharma Cred. Share Chart

REMOVE ADS

Biopharma Cred. News

BioPharma Credit Appoints Stephanie Leouzon As Non-Executive Director

LONDON (Alliance News) - BioPharma Credit PLC said Thursday it appointed Stephanie Leouzon as non-executive director with immediate effect.Currently, ...

BioPharma Placing Exceeds Upgraded Issue Size, Raises USD305 Million (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC on Thursday said it raised USD305 million after its proposed placing exceeded its upgraded issue size.Th...

BioPharma Credit C Shares Suspended From Trading Pending Announcement (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC's C shares were temporarily suspended from trading on the specialist fund segment of the London Stock Ex...

BioPharma Credit Increases Placing Size To USD200 Million (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Wednesday it increased the size of its proposed placing to "at least" USD200 million due to strong ...

BioPharma Credit increases placing following 'strong investor demand'

(Sharecast News) - BioPharma Credit has increased the size of its proposed placing to "at least" $200m on the back of investor demand that exceeded it...

BioPharma Credit To Raise USD150 Million Via Placing (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Friday it intends to raise USD150 million via share placing.The company will issue 146.3 million sh...

BioPharma Credit Interim Net Asset Value Flat, Income Rises Sharply

LONDON (Alliance News) - BioPhamra Credit PLC on Thursday reported a sharp rise in income in the first halfIn the six months ended June, the life scie...

BioPharma Credit Loans USD150 Million To Amicus Therapeutics

LONDON (Alliance News) - BioPharma Credit PLC said Thursday that it has loaned USD150 million to Amicus Therapeutics Inc, a rare metabolic disease-foc...